ARTICLE | Company News
Epitome, Medigene, Mitsui, Triton Pharma Inc. deal
April 25, 2011 7:00 AM UTC
MediGene granted Triton exclusive, Canadian rights to develop and commercialize Veregen sinecatechins ointment to treat genital warts. Triton will be responsible for Canadian approval of the topical formulation of polyphenols extracted from green tea leaves. MediGene is eligible for milestones of up to €2.1 million ($3 million), plus double-digit royalties. ...